Form 4: National Healthcare Corp Director Exercises Stock Options

Sentiment:

SEC Form 4


Sandra Y. Trail, a director at National Healthcare Corp, exercised stock options to acquire 1,886 shares of common stock at $69.19 per share.

Summary

  • On February 24, 2025, Sandra Y. Trail, a director of National Healthcare Corp (NHC), exercised stock options.
  • This transaction involved the acquisition of 1,886 shares of NHC common stock at a price of $69.19 per share.
  • Following the transaction, Trail directly owns 7,500 shares of common stock.
  • The exercised options were granted on May 5, 2022, under the 2020 Omnibus Equity Incentive Plan.
  • Trail also holds options to purchase 7,500 shares granted in 2023 at an exercise price of $55.75, and 7,500 shares granted in 2024 at an exercise price of $96.03.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports a standard transaction (stock option exercise) without any indication of positive or negative implications for the company.

Industry Context

Stock option exercises are a common form of executive compensation in the healthcare industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

  • Executive compensation packages, including stock options, are common in publicly traded healthcare companies like Brookdale Senior Living, Five Star Senior Living, and Life Care Centers of America.
  • The specific terms of option grants (exercise price, vesting schedule, expiration date) vary widely based on company size, performance, and individual executive roles.
  • Benchmarking against similar companies would require a detailed analysis of their executive compensation disclosures.

Stakeholder Impact

  • The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.

Key Dates

DateDescription
05/05/2022Date of grant for the exercised stock options under the 2020 Omnibus Equity Incentive Plan.
05/04/2024Date exercisable for 2023 option grant.
05/09/2025Date exercisable for 2024 option grant.
02/24/2025Date of the stock option exercise.
02/26/2025Date of signature on the Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.